See also this year's filing and all EDGAR filings for this company.
PDF Report 0001005201_2017_Assertio_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001005201')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001005201, Assertio Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 306,204,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 902,149,000 |
| 2 | PropertyPlantAndEquipmentNet | 15,526,000 |
| 3 | remainder_Assets | 1,458,000 |
| 4 | LiabilitiesCurrent | 227,242,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 204,498,000 |
| 9 | ResearchAndDevelopmentExpense | 32,631,000 |
| 10 | remainder_Expenses | 218,477,000 |
| 11 | remainder_Revenues | 455,897,000 |
| 12 | remainder_NetIncome | -89,011,000 |
| 13 | remainder_ComprehensiveNetIncome | 35,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,225,337,000 |
| 1 | Liabilities | 227,242,000 |
| 2 | Expenses | 455,606,000 |
| 3 | Revenues | 455,897,000 |
| 4 | StockholdersEquity | 998,095,000 |
| 5 | NetIncome | -88,720,000 |
| 6 | ComprehensiveNetIncome | -88,702,500 |
| 7 | BaseVar | 1,226,564,000 |
| 8 | EconomicCapitalRatio | 2.24 |
Edgar->Model Mapping
Feature Distribution
